Amphora Discovery Corporation recently announced it has entered into a multi-year research partnership with Ortho-McNeil Pharmaceutical, Inc.
NEW YORK (January 18, 2005) -- Callisto Pharmaceuticals, Inc., a biopharmaceutical company primarily focused on the development of drugs to treat cancer and osteolytic bone disease, has announced the appointment of Paula Craft to the newly-created position of Vice President, Regulatory Affairs.
ROCKVILLE, MD (January 18, 2005) -- The U.S. Pharmacopeia (USP) has announced that Susan S. de Mars, J.D., has joined USP as its new senior vice president and general counsel. She will replace Joseph G. Valentino, J.D., who retired in December after 35 years at USP.
PRINCETON, NJ (January 18,2005) -- Medarex, Inc., a biopharmaceutical company, and PharmAthene, Inc.
NORWALK, CT (January 18, 2005) – PharmaDiscovery 2005, produced by Elsevier’s Drug Discovery Today and Reed Exhibitions, announced a leading scientific line-up of speakers from the drug discovery community, at PharmaDiscovery on May 10-12, 2005, at the Washington, DC Convention Center.
REDWOOD CITY, CA (January 18, 2005) – Threshold Pharmaceuticals announced that Dr. Alan Colowick has been named Chief Medical Officer.
ROCKVILLE, MD (January 10, 2005) -- The U.S. Pharmacopeia (USP) has announced a collaborative research agreement with Health Canada's Health Products and Food Branch Inspectorate. The agreement became effective on September 7, 2004, and will remain in effect until March 2007.
MINNEAPOLIS, MN (January 10, 2005) -- The Executive Committee and Board of Directors have made a change of direction in the focus of the American Filtration & Separations Society (AFS).
LENOIR, NC (January 10, 2005) -- Greer Laboratories, Inc., a provider of allergy immunotherapy products and services, has received Food & Drug Administration (FDA) approval to begin Phase I safety and dosing studies focused on sublingual-oral administration of dust mite allergenic extracts.
BIRMINGHAM, United Kingdom (January 10, 2005) -- Aerotech Laboratories, Inc., an affiliate of STL and a part of the Aerotech P&K team, recently received its U.S. Drug Enforcement Agency (DEA) Registration for its Phoenix facility. This new registration allows Aerotech Laboratories, Inc.
KYOTO, Japan (January 10, 2005) – Omron Corp., a provider of automation, sensing, and control
By Michael Bridge Swagelok Company Cleanliness and drainability are among the most critical issues biopharmaceutical manufacturers or owner companies must confront with their process lines.
Company now offers a direct OEM replacement turret and stand assembly to fit the 3090/3200 and 2090/2200 series of tablet presses. The package is designed to be an affordable option for replacing or adding a turret and stand assembly to run on the 3090/3200 and 2090/2200 series of tablet presses.
Tablet press design has been mechanically modified to perform under strict production guidelines in order to help eliminate operator exposure to hazardous pharmaceutical products.
The single-sided Xpress 500 and double-sided Xpress 700 feature mpower integrated technology control which simplifies and expedites press setup times. The Xpress line features a stepped cabinet design for fast, easy and thorough cleaning procedures.